Moreover, our prior work revealed that MgT treatment clearly suppressed the expression of APH-1α/1β, the expression of which enhanced γ-cleavage of APP and resulted in Aβ deposition during the course of AD progression (Yu et al., 2015). The gene discussed is APP; the disease is Alzheimer disease.